Long-term surgical outcome in 16 patients with thyrotropin pituitary adenoma

Journal of Neurosurgery

Volumn 93, Issue 2, 2000, Pages 194-200

  Sanno, Naoko ^a   Teramoto, Akira ^b   Osamura, R Yoshiyuki ^b  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

Octreotide; Pituitary adenoma; Syndrome of inappropriate secretion of thyrotropin; Thyrotropin

Indexed keywords

ANTITHYROID AGENT; OCTREOTIDE; THYROTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; REMISSION; THYROTROPIN BLOOD LEVEL; THYROTROPIN RELEASE; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME; TUMOR RECURRENCE;

EID: 0033853092     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2000.93.2.0194     Document Type: Article

References (24)

1. Beckers A, Abs R, Mahler C, et al: Thyrotropin-secreting pituitary adenomas: report of seven cases. J Clin Endocrinol Metab 72:477-483, 1991
2. Beck-Peccoz P, Brucker-Davis F, Persani L, et al: Thyrotropin-secreting pituitary tumors. Endocrin Rev 17:610-638, 1996
3. Beck-Peccoz P, Persani L, Faglia G: Glycoprotein hormone α-subunit in pituitary adenomas. Trends Endocrinol Metab 3: 41-45, 1992
4. Beck-Peccoz P, Piscitelli G, Amr S, et al: Endocrine, biochemical, and morphological studies of a pituitary adenoma secreting growth hormone, thyrotropin (TSH) and α-subunit: evidence for secretion of TSH with increased bioactivity. J Clin Endocrinol Metab 62:704-711, 1986
5. Bertherat J, Brue T, Enjalbert A, et al: Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions. J Clin Endocrinol Metab 75:540-546, 1992
6. Brucker-Davis F, Oldfield EH, Skarulis MC, et al: Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab 84: 476-486, 1999
7. Chanson P, Weintraub BD, Harris AG: Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. A follow-up of 52 patients. Ann Intern Med 119:236-240, 1993
8. Comi RJ, Gesundheit N, Murray L, et al: Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue. N Engl J Med 317:12-17, 1987
9. Frandsen NJ, Transbøl I: [Basedow's disease and thyroid stimulating hormone producing pituitary adenoma in a patient.] Ugeskr Laeger 153:854-855, 1991 (Dan)
10. Gesundheit N, Petrick PA, Nissim M, et al: Thyrotropin-secreting pituitary adenomas. Clinical and biochemical heterogeneity: case reports and follow-up of nine patients. Ann Intern Med 11:827-835, 1989
11. Greenman Y, Melmed S: Thyrotropin-secreting pituitary tumors, in Melmed S (ed): The Pituitary. Boston: Blackwell, 1995, pp 546-558
12. Hill SA, Falko JM, Wilson CB, et al: Thyrotropin-producing pituitary adenomas. J Neurosurg 57:515-519, 1982
13. Kamoi K, Mitsuma T, Sato H, et al: Hyperthyroidism caused by a pituitary thyrotropin-secreting tumour with excessive secretion of thyrotropin-releasing hormone and subsequently followed by Graves' disease in a middle-aged woman. Acta Endocrinol 110:373-382, 1985
14. Kourides IA, Ridgway EC, Weintraub BD, et al: Thyrotropin-induced hyperthyroidism: use of alpha and beta subunit levels to identify patients with pituitary tumors. J Clin Endocrinol Metab 45:534-541, 1977
15. Losa M, Giovanelli M, Persani L, et al: Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 81:3084-3090, 1996
16. McCutcheon IE, Weintraub BD, Oldfield EH: Surgical treatment of thyrotropin-secreting pituitary adenomas. J Neurosurg 73:674-683, 1990
17. Mindermann T, Wilson CB: Thyrotropin-producing pituitary adenomas. J Neurosurg 79:521-527, 1993
18. Ridgway EC: Glycoprotein hormone production by pituitary tumors. Progr Endocrine Res Ther 1:343-350, 1984
19. Samuels MH, Wood WM, Gordon DF, et al: Clinical and molecular studies of a thyrotropin-secreting pituitary adenoma. J Clin Endocrinol Metab 68:1211 -1215, 1989
20. Sanno N, Teramoto A, Matsuno A, et al: Clinical and immunohistochemical studies on TSH-secreting pituitary adenoma: its multihormonality and expression of Pit-1. Mod Pathol 7: 893-899, 1994
21. Sanno N, Teramoto A, Matsuno A, et al: GH and PRL gene expression by nonradioisotopic in situ hybridization in TSH-secreting pituitary adenomas. J Clin Endocrinol Metab 80: 2518-2522, 1995
22. Stevenaert A, Harris AG, Kovacs K, et al: Presurgical octreotide treatment in acromegaly. Metabolism 41 (Suppl 2): 51-58, 1992
23. Warnet A, Lajeunie E, Gelbert F, et al: Shrinkage of primary thyrotropin-secreting pituitary adenoma treated with the long-acting somatostatin analogue octreotide (SMS 201-995). Acta Endocrinol 124:487-491, 1991
24. Wood DF, Johnston JM, Johnston DG: Dopamine, the dopamine D2 receptor and pituitary tumours. Clin Endocrinol 35: 455-466, 1991